Votre parcours vers l’agilité métier
Opérationnaliser les plans stratégiques - de la formulation à l'exécution dans toute l'organisation.
A product manager and an analyst are discussing the revenue forecast for a product in development. Poring over the financials, the manager asks: “Have you considered how SUPR-3 will impact sales of our other SUPR products?” The analyst replies confidently: “Yes! Right here you can see we are estimating SUPR-3 to take a...
It’s that time of year again: We find more requests for proposals (RFPs) in our inbox during the late summer and early fall than any other time of year. RFPs vary dramatically in length, complexity, and level of ambition. In a spirit of cooperation, allow me to make some suggestions about those RFPs, and about...
Dans les blogs précédents, APM : Combien vos applications vous coûtent-elles vraiment ? et APM : Pourquoi les organisations ne comprennent pas le coût total de possession (TCO) de leurs applications, je me suis concentré sur la façon dont les organisations peuvent commencer à déterminer la valeur technique et commerciale de leurs portefeuilles d'applications. Dans ce billet, j'aimerais me concentrer sur l'alignement des portefeuilles d'applications sur l'activité...
When we engage with a client, our primary objective is to ensure that they are investing in the right projects: Those in closest alignment with their strategic goals. Without proper attention paid to project execution, however, you’ll never unlock the potential of your chosen projects. Last year we blogged about the distinctions between operational and...
As we have said before, every forecast you’ll ever build is wrong. The truth may be out there, but due to a lack of perfect information about the future, you won’t be able to reveal it before your project review meeting. There is a paradox here: The more you insist on the truth, the more...
What is an R&D-driven company with $10-50 billion of cash in the bank to do? In the last twelve months, Merck, Pfizer, HP, AstraZeneca, and Bristol-Myers Squibb have announced stock buybacks totaling over $25 billion, and layoffs of over 30,000 employees. So apparently, for many firms, the best use of their cash hoard is a...
Finance and R&D can get along You’ve just finished briefing the executive committee on the methods for project valuation that you have worked so hard to establish in your R&D group. The team has finally acknowledged that risk needs to be managed in all its potential forms. You’ve reached consensus on the following set of...
Innovation is inherently risky. By definition, you’re doing something that you haven’t done before so there are no guarantees it will work. The mindset in many organizations is to “minimize” risk as if it were a disease, but it isn’t that simple. The best companies face risk head-on and manage it both systematically and transparently....
Detailed project valuations are often requested by executives, the basis being they will feel more confident in their decision making process if the accuracy of the forecasts is increased They might believe that adding detail to their valuations can accomplish this; however, this is inevitably not the case (All the NPVs are wrong, can we...
Another striking—and often underappreciated—aspect of [Steve] Jobs’ success was his ability to say no. At a company like Apple, thousands of ideas bubble up each year for new products and services that it could launch. The hardest thing for its leader is to decide which ones merit attention. Mr Jobs had an uncanny knack of...
